Danny A. Young Afat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Danny A. Young Afat has a total of 266 co-authors. Here are the top co-authors by number of shared publications:
- Helena M. Verkooijen
Division of Imaging and Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands
8 shared publications - Claudia Antoinette Bargon
Division of Imaging and Oncology, University Medical Centre Utrecht, Cancer Centre , Utrecht
6 shared publications Annemiek Doeksen
Department of Oncological Surgery, St. Antonius Hospital , Utrecht
5 shared publications- Hinne A. Rakhorst
Dept Plastic Surgery, Universitair Medisch Centrum Groningen, Groningen, the Netherlands
5 shared publications - Marc. A. M. Mureau
Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands
5 shared publications Helena M. Verkooijen
Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Imaging Division, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands
4 shared publications
Latest Publications
- 3 June 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 119, 65-72
HAND-Q: A global normative data sample of 1373 participants
- 3 June 2026
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 119, 65-72
HAND-Q: A global normative data sample of 1373 participants
- Open Access
- 23 March 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 195, 112250
Learning from every patient: the ‘outpatient innovation clinic’
- 23 March 2026
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 195, 112250
Open AccessLearning from every patient: the ‘outpatient innovation clinic’
- 9 March 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (4)
Longitudinal patient-reported outcomes of vaginal dilation after penile inversion vaginoplasty
Background: Penile inversion vaginoplasty (PIV) is a commonly performed gender-affirming procedure that requires postoperative dilation to maintain vaginal canal patency. Aim: To characterize patient-reported dilation experiences and evaluate temporal trends in postoperative outcomes. Methods: Consecutive patients undergoing primary PIV at a single center were prospectively surveyed at 1, 3, 6, 9, and 12 months postoperatively. Surveys were author-developed based on clinical experience and clinical review. Surveys assessed dilation frequency, session duration, depth achieved, and challenges encountered. Univariate analyzes were used to evaluate changes over time. Outcomes: The primary outcome was the proportion of patients reporting any dilation-related challenge over time. Secondary outcomes included adherence metrics (frequency, days/week, session duration), depth achieved, and specific challenges. Results: Seventeen of 27 patients completed all survey time points (63% response rate). On average, participants dilated 6.6 ± 1.4 days/week and 2.4 ± 0.9 times/day; sessions lasted 38.3 ± 16 minutes. Mean depth achieved was 4.05 ± 1.32 (13 cm standardized dilator set), with no significant decline over time. All patients reported at least one difficulty, most commonly tightness (71%), bleeding (71%), pain (65%), discharge (47%), and logistical barriers (24%). The prevalence of reported challenges declined significantly after six months (P < .05). Clinical Implications: Early dilation-related difficulties are nearly universal and should be anticipated with proactive counseling and structured postoperative support, though symptoms improve over time. Strengths and Limitations: This is the first prospective, longitudinal study of dilation following PIV, using an author-developed survey instrument to capture patient-reported outcomes. Limitations include modest sample size, potential response bias, and lack of assessment of challenge severity. Conclusion: Reported dilation adherence following PIV is high, but most patients experience early challenges that diminish over time, highlighting the need for anticipatory counseling and individualized, symptom-responsive dilation protocols.
- 9 March 2026
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 23 (4)
Longitudinal patient-reported outcomes of vaginal dilation after penile inversion vaginoplasty
Background: Penile inversion vaginoplasty (PIV) is a commonly performed gender-affirming procedure that requires postoperative dilation to maintain vaginal canal patency. Aim: To characterize patient-reported dilation experiences and evaluate temporal trends in postoperative outcomes. Methods: Consecutive patients undergoing primary PIV at a single center were prospectively surveyed at 1, 3, 6, 9, and 12 months postoperatively. Surveys were author-developed based on clinical experience and clinical review. Surveys assessed dilation frequency, session duration, depth achieved, and challenges encountered. Univariate analyzes were used to evaluate changes over time. Outcomes: The primary outcome was the proportion of patients reporting any dilation-related challenge over time. Secondary outcomes included adherence metrics (frequency, days/week, session duration), depth achieved, and specific challenges. Results: Seventeen of 27 patients completed all survey time points (63% response rate). On average, participants dilated 6.6 ± 1.4 days/week and 2.4 ± 0.9 times/day; sessions lasted 38.3 ± 16 minutes. Mean depth achieved was 4.05 ± 1.32 (13 cm standardized dilator set), with no significant decline over time. All patients reported at least one difficulty, most commonly tightness (71%), bleeding (71%), pain (65%), discharge (47%), and logistical barriers (24%). The prevalence of reported challenges declined significantly after six months (P < .05). Clinical Implications: Early dilation-related difficulties are nearly universal and should be anticipated with proactive counseling and structured postoperative support, though symptoms improve over time. Strengths and Limitations: This is the first prospective, longitudinal study of dilation following PIV, using an author-developed survey instrument to capture patient-reported outcomes. Limitations include modest sample size, potential response bias, and lack of assessment of challenge severity. Conclusion: Reported dilation adherence following PIV is high, but most patients experience early challenges that diminish over time, highlighting the need for anticipatory counseling and individualized, symptom-responsive dilation protocols.
- Open Access
- 29 November 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 113, 547-555
Superior gluteal artery perforator flap for autologous breast reconstruction: Refined surgical technique, outcomes, and patient satisfaction
- 29 November 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 113, 547-555
Open AccessSuperior gluteal artery perforator flap for autologous breast reconstruction: Refined surgical technique, outcomes, and patient satisfaction
- Open Access
- 1 August 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (8)
Effectiveness of a patient decision aid for women considering post-mastectomy breast reconstruction: randomized controlled trial
Background: Post-mastectomy breast reconstruction (PMBR) improves quality of life, yet decisions regarding type and timing are complex, requiring careful consideration of risks, benefits, and personal preferences. Shared decision-making enhances satisfaction with reconstructive decisions, but some women experience difficulty participating effectively. This study evaluated the effectiveness of a PMBR-specific patient decision aid (pDA) compared with high-quality standard care. Methods: In this single-centre RCT, women eligible for PMBR were assigned in a 1:1 ratio to either standard care alone (control) or standard care and a pDA (intervention). Questionnaires were completed at baseline, after reconstructive decision, and at 1-year post-surgery. The primary outcome was decisional conflict after the decision. Secondary outcomes included measures for the decision-making process, patient-reported, and surgical outcomes. Between-group differences were analysed using t-tests, Mann–Whitney U tests, and chi-square tests. Mean differences (MD) with 95% confidence intervals quantified outcomes, while effect sizes were determined by Cohen’s d. Results: A total of 134 patients were enrolled (66 intervention, 68 control). Both groups reported consistently low decisional conflict (17 and 20 respectively). No significant differences were found in the primary (MD −2.8, 95% c.i., −8.4 to 2.8, Cohen’s d −0.18) or secondary outcomes immediately after reconstructive decision or 1-year post-surgery. Conclusion: In a population with access to high-quality multidisciplinary care, an online pDA for PMBR did not provide additional benefits over standard care. Both approaches effectively supported reconstructive decision-making, resulting in consistently low levels of decisional conflict. Trial registration number: NL-OMON28003 (NTR), NL7939 (NTR-new)
- 1 August 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (8)
Open AccessEffectiveness of a patient decision aid for women considering post-mastectomy breast reconstruction: randomized controlled trial
Background: Post-mastectomy breast reconstruction (PMBR) improves quality of life, yet decisions regarding type and timing are complex, requiring careful consideration of risks, benefits, and personal preferences. Shared decision-making enhances satisfaction with reconstructive decisions, but some women experience difficulty participating effectively. This study evaluated the effectiveness of a PMBR-specific patient decision aid (pDA) compared with high-quality standard care. Methods: In this single-centre RCT, women eligible for PMBR were assigned in a 1:1 ratio to either standard care alone (control) or standard care and a pDA (intervention). Questionnaires were completed at baseline, after reconstructive decision, and at 1-year post-surgery. The primary outcome was decisional conflict after the decision. Secondary outcomes included measures for the decision-making process, patient-reported, and surgical outcomes. Between-group differences were analysed using t-tests, Mann–Whitney U tests, and chi-square tests. Mean differences (MD) with 95% confidence intervals quantified outcomes, while effect sizes were determined by Cohen’s d. Results: A total of 134 patients were enrolled (66 intervention, 68 control). Both groups reported consistently low decisional conflict (17 and 20 respectively). No significant differences were found in the primary (MD −2.8, 95% c.i., −8.4 to 2.8, Cohen’s d −0.18) or secondary outcomes immediately after reconstructive decision or 1-year post-surgery. Conclusion: In a population with access to high-quality multidisciplinary care, an online pDA for PMBR did not provide additional benefits over standard care. Both approaches effectively supported reconstructive decision-making, resulting in consistently low levels of decisional conflict. Trial registration number: NL-OMON28003 (NTR), NL7939 (NTR-new)
- 1 July 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (8) , 1753-1755
Response to Yuan, Zheng, and Zang
- 1 July 2025
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (8) , 1753-1755
Response to Yuan, Zheng, and Zang
- Open Access
- 16 June 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 209, 110991
Neoadjuvant radiotherapy and immediate breast reconstruction: A systematic review of literature of the last decade
- 16 June 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 209, 110991
Open AccessNeoadjuvant radiotherapy and immediate breast reconstruction: A systematic review of literature of the last decade
- Open Access
- 8 January 2025
- Published by Elsevier in JPRAS Open
- Vol. 43, 475-490
Comprehensive Assessment of Specific Patient-Reported Outcome Measures for Hand and Wrist Conditions in Adults: A Scoping Review
- 8 January 2025
- Published by Elsevier in JPRAS Open
- Vol. 43, 475-490
Open AccessComprehensive Assessment of Specific Patient-Reported Outcome Measures for Hand and Wrist Conditions in Adults: A Scoping Review
- 29 November 2024
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (4) , 781-789
Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study
Background: Oncoplastic breast-conserving surgery (OP-BCS) is becoming increasingly popular to avoid mastectomy or optimize cosmetic outcomes of breast-conserving surgery (BCS). Few studies have compared clinical outcomes and patient-reported outcomes (PROs) of OP-BCS to conventional BCS (C-BCS). This study aims to compare clinical outcomes and short- and long-term PROs after OP-BCS and C-BCS in a large prospective breast cancer cohort. Methods: Women in the prospective, multicenter UMBRELLA (Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion) breast cancer cohort who underwent OP-BCS or C-BCS were included. Clinical outcomes and PROs (measured by EORTC QLQ-C30/BR23) up to 24 months postoperatively were evaluated. Mixed-model analysis was performed to assess differences in PROs over time between groups. Results: A total of 1628 (84.9%) patients received C-BCS and 290 (15.1%) received OP-BCS. After C-BCS and OP-BCS, free resection margins were obtained in 84.2% (n = 1370) and 86.2% (n = 250), respectively, reoperation for re-excision of margins within 3 months occurred in 5.3% (n = 86) and 4.8% (n = 14), and the median time interval from surgery until adjuvant systemic therapy was 66 and 63 days, and 36 and 41 days until radiotherapy. Shortly postoperative, OP-BCS was associated with statistically significant lower mean scores for physical functioning (83.6 vs 87.2) and body image (82.8 vs 89.4) and more pain (19.8 vs 26.5) and breast symptoms (22.7 vs 30.3) than C-BCS. Body image scores remained statistically significantly less favorable after OP-BSC than C-BCS up to 24 months postoperatively (87.8 vs 92.2). Conclusions: Oncoplastic surgery safely enables BCS but may lead to less favorable long-term body image compared to C-BCS. These findings are important for patient education and shared decision-making.
- 29 November 2024
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 117 (4) , 781-789
Clinical and patient-reported outcomes after oncoplastic vs conventional breast-conserving surgery—a longitudinal, multicenter cohort study
Background: Oncoplastic breast-conserving surgery (OP-BCS) is becoming increasingly popular to avoid mastectomy or optimize cosmetic outcomes of breast-conserving surgery (BCS). Few studies have compared clinical outcomes and patient-reported outcomes (PROs) of OP-BCS to conventional BCS (C-BCS). This study aims to compare clinical outcomes and short- and long-term PROs after OP-BCS and C-BCS in a large prospective breast cancer cohort. Methods: Women in the prospective, multicenter UMBRELLA (Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion) breast cancer cohort who underwent OP-BCS or C-BCS were included. Clinical outcomes and PROs (measured by EORTC QLQ-C30/BR23) up to 24 months postoperatively were evaluated. Mixed-model analysis was performed to assess differences in PROs over time between groups. Results: A total of 1628 (84.9%) patients received C-BCS and 290 (15.1%) received OP-BCS. After C-BCS and OP-BCS, free resection margins were obtained in 84.2% (n = 1370) and 86.2% (n = 250), respectively, reoperation for re-excision of margins within 3 months occurred in 5.3% (n = 86) and 4.8% (n = 14), and the median time interval from surgery until adjuvant systemic therapy was 66 and 63 days, and 36 and 41 days until radiotherapy. Shortly postoperative, OP-BCS was associated with statistically significant lower mean scores for physical functioning (83.6 vs 87.2) and body image (82.8 vs 89.4) and more pain (19.8 vs 26.5) and breast symptoms (22.7 vs 30.3) than C-BCS. Body image scores remained statistically significantly less favorable after OP-BSC than C-BCS up to 24 months postoperatively (87.8 vs 92.2). Conclusions: Oncoplastic surgery safely enables BCS but may lead to less favorable long-term body image compared to C-BCS. These findings are important for patient education and shared decision-making.